Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Collaborative care model to improve outcomes in major depression.

Denise M Boudreau1, Kam L Capoccia, Sean D Sullivan

  • 1Department of Pharmacy, University of Washington, Seattle, WA 98195-7630, USA. dboudreau@u.washington.edu

The Annals of Pharmacotherapy
|March 29, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neural tube defect risk in relation to opioid analgesic exposure during early pregnancy.

American journal of epidemiology·2025
Same author

Use of Real-World Claims Data to Assess the Prevalence of Concomitant Medications to Inform Drug-Drug Interaction Risk in Target Patient Populations.

Clinical pharmacology and therapeutics·2025
Same author

Drugs anticipated to be selected for the Medicare Drug Price Negotiation Program in 2025.

Journal of managed care & specialty pharmacy·2024
Same author

A systematic literature review of the clinical and socioeconomic burden of bronchiectasis.

European respiratory review : an official journal of the European Respiratory Society·2024
Same author

Telemedicine Use Before and During the COVID-19 Pandemic in People with Alzheimer's Disease, Multiple Sclerosis, or Parkinson's Disease: A Cross-Sectional Study Using US Commercial Claims Data.

Telemedicine reports·2024
Same author

Integrating Price Benchmarks and Comparative Clinical Effectiveness to Inform the Medicare Drug Price Negotiation Program.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2024

A pharmacist intervention improved depression care in primary care. This enhanced care model involved pharmacists collaborating with providers to manage antidepressant treatment, potentially improving patient outcomes.

Area of Science:

  • Primary care research
  • Clinical pharmacy
  • Mental health services research

Background:

  • Depression is a prevalent condition requiring effective management in primary care.
  • Current primary care models may not fully optimize depression treatment outcomes.

Purpose of the Study:

  • To develop and evaluate a pharmacist-led collaborative care intervention to enhance depression management in a primary care setting.
  • To assess the impact of this intervention on depression symptom reduction and other patient-centered outcomes.

Main Methods:

  • A pragmatic, randomized trial comparing enhanced care (EC) with usual care (UC) was conducted in an academic family practice clinic.
  • Seventy-four patients with new major depression diagnoses received either EC (pharmacist-provider collaboration) or UC.

Related Experiment Videos

  • Outcomes measured included depression symptom severity (SCL-20), DSM-IV criteria, quality of life (SF-12), adherence, satisfaction, and healthcare utilization.

    • Main Results:

    • The enhanced care model involved clinical pharmacists collaborating with primary care providers (PCPs) to manage antidepressant initiation, titration, adherence, and relapse prevention.
    • Patients in the enhanced care group received comprehensive management from their PCPs.
    • Key outcome measures included depression symptom reduction, quality of life, medication adherence, patient satisfaction, and healthcare utilization, with cost-effectiveness analysis planned.

    Conclusions:

    • This ongoing trial is exploring a novel collaborative care approach for depression in primary care.
    • The findings may highlight new roles for clinical pharmacists in integrated behavioral healthcare.
    • The study has the potential to significantly impact how depression is treated within primary care settings.